U.S. Markets closed

Dechra Pharmaceuticals plc (DPH.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
1,990.00+18.00 (+0.91%)
At close: 4:35PM BST

Dechra Pharmaceuticals plc

24 Cheshire Avenue
Cheshire Business Park
Northwich CW9 7UA
United Kingdom
44 1606 814 730
http://www.dechra.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees1,344

Key Executives

NameTitlePayExercisedAge
Mr. Ian D. PageCEO, MD & Exec. DirectorN/AN/A56
Mr. Richard John Cotton BA Hons, FCMACFO & Director381kN/A56
Dr. Anthony Gerard GriffinMD of Dechra Veterinary Products for Europe & Exec. DirectorN/AN/A54
Ms. Katy CloughGroup HR DirectorN/AN/AN/A
Mr. Mike Eldred BA, MBAPres of North AmericaN/AN/A47
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Dechra Pharmaceuticals plc develops, manufactures, sells, and markets veterinary pharmaceuticals and related products for veterinarians worldwide. The company operates through the European Pharmaceuticals, the North American Pharmaceuticals, and the Pharmaceuticals Research and Development segments. It offers various endocrinology, dermatology and care, anesthesia and analgesia, cardiovascular disease, ophthalmology, and equine medicine products; food producing animal antimicrobials; poultry vaccines; and pet diets. The company markets and distributes veterinary pharmaceuticals and equipment; provides financial services; and manufactures human and veterinary pharmaceutical products for third party customers. Dechra Pharmaceuticals plc markets its products through wholesaler and distributor networks. The company was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Corporate Governance

Dechra Pharmaceuticals plc’s ISS Governance QualityScore as of September 1, 2017 is 5. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.